BTC $78,606.92 -0.56%
ETH $2,491.71 +0.15%
BNB $753.63 +1.93%
XRP $1.42 +1.85%
SOL $103.67 +0.01%
TRX $0.3390 +1.38%
DOGE $0.0905 -0.27%
ADA $0.2203 -0.30%
BCH $258.99 -0.04%
LINK $12.55 -1.51%
HYPE $85.39 +0.35%
AAVE $129.16 -2.19%
SUI $0.8194 -0.05%
XLM $0.1883 -2.68%
ZEC $1,181.31 +3.72%
BTC $78,606.92 -0.56%
ETH $2,491.71 +0.15%
BNB $753.63 +1.93%
XRP $1.42 +1.85%
SOL $103.67 +0.01%
TRX $0.3390 +1.38%
DOGE $0.0905 -0.27%
ADA $0.2203 -0.30%
BCH $258.99 -0.04%
LINK $12.55 -1.51%
HYPE $85.39 +0.35%
AAVE $129.16 -2.19%
SUI $0.8194 -0.05%
XLM $0.1883 -2.68%
ZEC $1,181.31 +3.72%

The judge ruled that Bitfarms must immediately terminate its "poison pill" strategy aimed at opposing Riot Platforms' acquisition

2024-07-25 13:58:35

ChainCatcher news, the encrypted mining company Riot Platforms stated in a declaration on July 24 that the Ontario Capital Markets Tribunal issued a cease trading order on Bitfarms' poison pill plan, immediately terminating the strategy.

Since June 13, Bitfarms has been opposing Riot Platforms' $950 million acquisition offer, claiming that Riot unfairly undervalued the company. The company adopted a poison pill strategy known as a "rights plan" to attempt to block the acquisition.

Poison pill strategies are typically used by companies to prevent hostile takeovers. Under this strategy, existing shareholders purchase additional shares at a significant discount, diluting the value of the shares held by the acquirer. According to Bitfarms' now-defunct rights plan, if any entity acquires more than 15% of the company's outstanding shares before September 10, Bitfarms will issue new shares to other existing shareholders, thereby reducing that entity's ownership.

app_icon
ChainCatcher Building the Web3 world with innovations.